Association Between NOS3 Gene G894T Polymorphism and Late-onset Alzheimer Disease in a Sample From Iran

被引:8
作者
Azizi, Zahra [1 ]
Noroozian, Maryam [3 ]
Kaini-Moghaddam, Zahra [2 ]
Majlessi, Nahid [1 ]
机构
[1] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran 1316943551, Iran
[2] Pasteur Inst Iran, Dept Biotechnol, Tehran 1316943551, Iran
[3] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Memory Clin, Dept Memory & Behav Neurol, Tehran, Iran
关键词
Alzheimer disease; endothelial nitric oxide synthase (NOS3); polymorphism; case-control study; risk factor; NITRIC-OXIDE SYNTHASE; GLU298ASP POLYMORPHISM; ABERRANT EXPRESSION; HOMOCYSTEINE LEVELS; OXIDATIVE STRESS; RISK; NEURODEGENERATION; INFLAMMATION; RELEVANCE; DEMENTIA;
D O I
10.1097/WAD.0b013e3181a7c8fd
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer disease (AD) is the most common age-associated neurodegenerative disease caused by complicated interactions between genetic and environmental factors. The presence of the apolipoprotein epsilon 4 allele, the only confirmed genetic risk factor for late-onset AD (LOAD), is neither sufficient nor necessary to explain all occurrences of the disease. Aberrant expression of the endothelial nitric oxide synthase (NOS3) gene has been demonstrated in degenerating neurons and glial cells in brains with AD. Molecular epidemiologic studies have presented contradictory results concerning a potential role of NOS3 gene G894T polymorphism in AD. To de. ne a possible association of this polymorphism with LOAD in an Iranian population, we conducted a case-control study including a clinically well-defined group of 100 LOAD patients and 100 age-matched controls. G894T polymorphism in NOS3 gene was determined by polymerase chain reaction-restriction fragment length polymorphisms assay. Chi-square analysis showed a significantly increased number of individuals with the G/G genotype in AD patients compared with controls (P < 0.05). These results demonstrate an association between G894T polymorphism and LOAD in an Iranian sample and the G/G genotype seems to have some effects in the development of AD either alone or through interaction with other risk factors.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 42 条
  • [1] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [2] Genetic association between endothelial nitric oxide synthase and Alzheimer disease
    Akomolafe, A.
    Lunetta, K. L.
    Erlich, P. M.
    Cupples, L. A.
    Baldwin, C. T.
    Huyck, M.
    Green, R. C.
    Farrer, L. A.
    [J]. CLINICAL GENETICS, 2006, 70 (01) : 49 - 56
  • [3] Genetic evidence that nitric oxide modulates homocysteine -: The NOS3 894TT genotype is a risk factor for hyperhomocystenemia
    Brown, KS
    Kluijtmans, LAJ
    Young, IS
    Woodside, J
    Yarnell, JWG
    McMaster, D
    Murray, L
    Evans, AE
    Boreham, CA
    McNulty, H
    Strain, JJ
    Mitchell, LE
    Whitehead, AS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) : 1014 - 1020
  • [4] Cacabelos Ramon, 2008, V448, P213, DOI 10.1007/978-1-59745-205-2_10
  • [5] Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: The ATTICA study
    Chrysohoou, C
    Panagiotakos, DB
    Pitsavos, C
    Antoniades, C
    Skoumas, J
    Brown, M
    Stefanadis, C
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (04) : 733 - 738
  • [6] Endothelial nitric oxide synthase gene: prospects for treatment of heart disease
    Cooke, Glen E.
    Doshi, Amit
    Binkley, Philip F.
    [J]. PHARMACOGENOMICS, 2007, 8 (12) : 1723 - 1734
  • [7] Crawford F, 2000, ANN NEUROL, V47, P687, DOI 10.1002/1531-8249(200005)47:5<687::AID-ANA30>3.0.CO
  • [8] 2-4
  • [9] Dahiyat M, 1999, ANN NEUROL, V46, P664, DOI 10.1002/1531-8249(199910)46:4<664::AID-ANA18>3.0.CO
  • [10] 2-J